UNITED STATES ANTIMONY CORP (UAMY) Fundamental Analysis & Valuation

NYSE:UAMY • US9115491030

Current stock price

9.34 USD
-0.96 (-9.32%)
At close:
9.45 USD
+0.11 (+1.18%)
After Hours:

This UAMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. UAMY Profitability Analysis

1.1 Basic Checks

  • In the past year UAMY has reported negative net income.
  • UAMY had a negative operating cash flow in the past year.
  • In the past 5 years UAMY reported 4 times negative net income.
  • UAMY had negative operating cash flow in 4 of the past 5 years.
UAMY Yearly Net Income VS EBIT VS OCF VS FCFUAMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

  • The Return On Assets of UAMY (-1.87%) is comparable to the rest of the industry.
  • UAMY's Return On Equity of -2.37% is in line compared to the rest of the industry. UAMY outperforms 53.50% of its industry peers.
Industry RankSector Rank
ROA -1.87%
ROE -2.37%
ROIC N/A
ROA(3y)-8.85%
ROA(5y)-10.39%
ROE(3y)-9.93%
ROE(5y)-15.31%
ROIC(3y)N/A
ROIC(5y)N/A
UAMY Yearly ROA, ROE, ROICUAMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

  • The Gross Margin of UAMY (25.90%) is better than 62.42% of its industry peers.
  • In the last couple of years the Gross Margin of UAMY has grown nicely.
  • The Profit Margin and Operating Margin are not available for UAMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.95%
GM growth 5YN/A
UAMY Yearly Profit, Operating, Gross MarginsUAMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. UAMY Health Analysis

2.1 Basic Checks

  • UAMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • UAMY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, UAMY has more shares outstanding
  • UAMY has a worse debt/assets ratio than last year.
UAMY Yearly Shares OutstandingUAMY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
UAMY Yearly Total Debt VS Total AssetsUAMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • UAMY has an Altman-Z score of 86.11. This indicates that UAMY is financially healthy and has little risk of bankruptcy at the moment.
  • UAMY's Altman-Z score of 86.11 is amongst the best of the industry. UAMY outperforms 92.36% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that UAMY is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.00, UAMY is doing good in the industry, outperforming 77.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 86.11
ROIC/WACCN/A
WACC11.76%
UAMY Yearly LT Debt VS Equity VS FCFUAMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.21 indicates that UAMY has no problem at all paying its short term obligations.
  • The Current ratio of UAMY (2.21) is comparable to the rest of the industry.
  • A Quick Ratio of 1.36 indicates that UAMY should not have too much problems paying its short term obligations.
  • UAMY has a Quick ratio (1.36) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.36
UAMY Yearly Current Assets VS Current LiabilitesUAMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. UAMY Growth Analysis

3.1 Past

  • UAMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.59%, which is quite impressive.
  • Looking at the last year, UAMY shows a very strong growth in Revenue. The Revenue has grown by 178.66%.
  • Measured over the past years, UAMY shows a quite strong growth in Revenue. The Revenue has been growing by 12.56% on average per year.
EPS 1Y (TTM)78.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%380%
Revenue 1Y (TTM)178.66%
Revenue growth 3Y24.46%
Revenue growth 5Y12.56%
Sales Q2Q%274.05%

3.2 Future

  • UAMY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 86.40% yearly.
  • Based on estimates for the next years, UAMY will show a very strong growth in Revenue. The Revenue will grow by 87.80% on average per year.
EPS Next Y100%
EPS Next 2Y242.78%
EPS Next 3Y179.5%
EPS Next 5Y86.4%
Revenue Next Year178.87%
Revenue Next 2Y197.95%
Revenue Next 3Y162.73%
Revenue Next 5Y87.8%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UAMY Yearly Revenue VS EstimatesUAMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
UAMY Yearly EPS VS EstimatesUAMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. UAMY Valuation Analysis

4.1 Price/Earnings Ratio

  • UAMY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 46.96, the valuation of UAMY can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of UAMY is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of UAMY to the average of the S&P500 Index (24.12), we can say UAMY is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 46.96
UAMY Price Earnings VS Forward Price EarningsUAMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UAMY Per share dataUAMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • UAMY's earnings are expected to grow with 179.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y242.78%
EPS Next 3Y179.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UAMY Dividend Analysis

5.1 Amount

  • UAMY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UAMY Fundamentals: All Metrics, Ratios and Statistics

UNITED STATES ANTIMONY CORP

NYSE:UAMY (3/18/2026, 5:49:01 PM)

After market: 9.45 +0.11 (+1.18%)

9.34

-0.96 (-9.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-12
Earnings (Next)04-06
Inst Owners43.92%
Inst Owner Change19.6%
Ins Owners3.05%
Ins Owner Change-0.06%
Market Cap1.31B
Revenue(TTM)26.82M
Net Income(TTM)-889.80K
Analysts84
Price Target11.14 (19.27%)
Short Float %21.9%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.83%
Min Revenue beat(2)-17.56%
Max Revenue beat(2)3.9%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.93%
PT rev (3m)12.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 46.96
P/S 48.77
P/FCF N/A
P/OCF N/A
P/B 34.87
P/tB 34.87
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.2
Fwd EY2.13%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.19
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.87%
ROE -2.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.9%
FCFM N/A
ROA(3y)-8.85%
ROA(5y)-10.39%
ROE(3y)-9.93%
ROE(5y)-15.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.95%
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 538.64%
Cap/Sales 28.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 1.36
Altman-Z 86.11
F-Score5
WACC11.76%
ROIC/WACCN/A
Cap/Depr(3y)129.62%
Cap/Depr(5y)97.98%
Cap/Sales(3y)12.03%
Cap/Sales(5y)9.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%380%
EPS Next Y100%
EPS Next 2Y242.78%
EPS Next 3Y179.5%
EPS Next 5Y86.4%
Revenue 1Y (TTM)178.66%
Revenue growth 3Y24.46%
Revenue growth 5Y12.56%
Sales Q2Q%274.05%
Revenue Next Year178.87%
Revenue Next 2Y197.95%
Revenue Next 3Y162.73%
Revenue Next 5Y87.8%
EBIT growth 1Y68.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-101.44%
EBIT Next 3Y234.42%
EBIT Next 5Y108.51%
FCF growth 1Y-22.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.66%
OCF growth 3YN/A
OCF growth 5YN/A

UNITED STATES ANTIMONY CORP / UAMY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UNITED STATES ANTIMONY CORP?

ChartMill assigns a fundamental rating of 4 / 10 to UAMY.


What is the valuation status of UNITED STATES ANTIMONY CORP (UAMY) stock?

ChartMill assigns a valuation rating of 2 / 10 to UNITED STATES ANTIMONY CORP (UAMY). This can be considered as Overvalued.


What is the profitability of UAMY stock?

UNITED STATES ANTIMONY CORP (UAMY) has a profitability rating of 2 / 10.


Is the dividend of UNITED STATES ANTIMONY CORP sustainable?

The dividend rating of UNITED STATES ANTIMONY CORP (UAMY) is 0 / 10 and the dividend payout ratio is 0%.